Efficacy and Safety of Safflower Yellow in Early Diabetic Nephropathy: A Meta-Analysis.
Xiuze JinLiuyan ShiFeng ChangYun LuPublished in: Evidence-based complementary and alternative medicine : eCAM (2019)
Conventional therapy combined with safflower yellow had a more beneficial effect than conventional therapy alone in early DN patients. There were significant differences in effective rate, urinary albumin excretion rates, fasting blood glucose, serum creatinine, and blood urea nitrogen between the two regimens and no significant difference in adverse events. More randomized controlled research using standardized protocols would be needed in the future to compare these two regimens.
Keyphrases
- blood glucose
- diabetic nephropathy
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- glycemic control
- prognostic factors
- randomized controlled trial
- double blind
- type diabetes
- insulin resistance
- clinical trial
- stem cells
- uric acid
- patient reported outcomes
- phase ii
- cell therapy
- metabolic syndrome